According to a research report published by Spherical Insights & Consulting, the United States bone pain treatment market is anticipated to reach USD 3.10 billion by 2035, growing at a CAGR of 6.38% from 2025 to 2035. The U.S. bone pain treatment market is growing due to an aging population, rising prevalence of bone disorders like arthritis and osteoporosis, and advancements in therapies such as biologics and minimally invasive procedures. Increased healthcare access and greater public awareness also boost treatment rates, collectively driving strong demand for innovative and effective bone pain management solutions. The United States bone pain treatment market refers to the segment of the healthcare industry focused on diagnosing and managing pain caused by bone-related disorders, including arthritis, osteoporosis, fractures, and cancer-related bone pain.